Michelle L Kraus

Title: Michelle L Kraus: Innovator in Biochemical Research

Introduction

Michelle L Kraus is a prominent inventor based in Temecula, CA (US). She has made significant contributions to the field of biochemical research, particularly in the area of crystallization techniques for various proteins. With a total of 3 patents to her name, her work has implications for drug development and therapeutic applications.

Latest Patents

Among her latest patents is the "Crystallization of the catalytic domain of human phosphodiesterase 4-D3 (PDE4-D3)." This patent provides methods for forming crystals comprising PDE4-D3 and includes crystals co-crystallized with a ligand molecule. Another notable patent is the "Crystallization of MAPK/ERK Kinase 2," which relates to human mitogen-activated protein kinase kinase2 (MAPKK2), also known as MAPK/ERK Kinase2 (MEK2), detailing its various uses.

Career Highlights

Michelle currently works at Takeda San Diego, Inc., where she continues to advance her research in biochemistry. Her innovative approaches have garnered attention in the scientific community, contributing to the understanding of critical biochemical pathways.

Collaborations

She has collaborated with esteemed colleagues such as Douglas R Dougan and Clifford D Mol, further enhancing the impact of her research through teamwork and shared expertise.

Conclusion

Michelle L Kraus exemplifies the spirit of innovation in the field of biochemical research. Her patents and ongoing work at Takeda San Diego, Inc. highlight her commitment to advancing scientific knowledge and therapeutic solutions.